| 1 |
doxorubicin
(11118 times)
|
Pharmacology
(1839 times)
|
MDR (569 times)
ROS (546 times)
P-gp (390 times)
|
1979 Effects of daunorubicin and doxorubicin, free and associated with DNA, on hemopoietic stem cells.
|
| 2 |
doxycycline
(977 times)
|
Molecular Biology
(122 times)
|
TET (69 times)
TRE (27 times)
rtTA (26 times)
|
1993 Effect of tetracyclines which have metalloproteinase inhibitory capacity on basal and heparin-stimulated bone resorption by chick osteoclasts.
|
| 3 |
doxorubicin hydrochloride
(516 times)
|
Chemistry
(110 times)
|
NIR (31 times)
NPs (28 times)
MSNs (23 times)
|
1986 Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease.
|
| 4 |
doxazosin
(30 times)
|
Pharmacology
(6 times)
|
ALF (4 times)
BP (4 times)
BPH (3 times)
|
1987 A 24-week multicenter double-blind study of doxazosin and hydrochlorothiazide in patients with mild to moderate essential hypertension.
|
| 5 |
doxepin
(27 times)
|
Pharmacology
(8 times)
|
AMI (8 times)
IMI (5 times)
DDOX (4 times)
|
1978 Doxepin kinetics.
|
| 6 |
copolymer-doxorubicin
(20 times)
|
Pharmacology
(8 times)
|
HPMA (10 times)
MW (2 times)
RAFT (2 times)
|
1999 Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1.
|
| 7 |
drug-doxorubicin
(16 times)
|
Pharmacology
(4 times)
|
MDR (2 times)
PTT (2 times)
ROS (2 times)
|
2002 Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates.
|
| 8 |
dioxygenase
(14 times)
|
Biochemistry
(8 times)
|
AOS (6 times)
LDS (5 times)
EAS (3 times)
|
1994 Construction of hybrid biphenyl (bph) and toluene (tod) genes for functional analysis of aromatic ring dioxygenases.
|
| 9 |
docetaxel
(13 times)
|
Biochemistry
(3 times)
|
PCa (2 times)
3'UTRs (1 time)
AEs (1 time)
|
2009 Weekly administration of docetaxel and epirubicin as first-line treatment for hormone-refractory prostate carcinoma.
|
| 10 |
doxycycline hyclate
(12 times)
|
Pharmacology
(2 times)
|
beta-CD (1 time)
CAA (1 time)
CNC (1 time)
|
2007 Intra-articular administration of doxycycline in calves.
|
| 11 |
doxycycline hydrochloride
(11 times)
|
Environmental Health
(4 times)
|
TYT (3 times)
BET (2 times)
XRD (2 times)
|
2000 Expression of wild-type and noncleavable Fas ligand by tetracycline-regulated adenoviral vectors to limit intimal hyperplasia in vascular lesions.
|
| 12 |
doxorubicin HCl
(7 times)
|
Pharmacology
(2 times)
|
PLLA (2 times)
CEL (1 time)
CNTs (1 time)
|
2010 Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
|
| 13 |
doxylamine succinate
(7 times)
|
Chemistry Techniques, Analytical
(2 times)
|
PYR (4 times)
RP-HPLC (2 times)
CAF (1 time)
|
1999 Simultaneous determination of pyridoxine hydrochloride and doxylamine succinate from tablets by ion pair reversed-phase high-performance liquid chromatography (RP-HPLC).
|
| 14 |
docetaxel plus oxaliplatin and capecitabine
(5 times)
|
Neoplasms
(2 times)
|
ORR (2 times)
CR (1 time)
DCF (1 time)
|
2010 [Efficacy and safety evaluation of docetaxel plus oxaliplatin and capecitabine in the treatment of advanced gastric adenocarcinoma: a single center non-controlled phase II clinical trial].
|
| 15 |
doxazosin mesylate
(5 times)
|
Biochemistry
(2 times)
|
LOD (2 times)
TER (2 times)
ALF (1 time)
|
2002 Flow injection analysis of doxazosin mesylate using UV-detection.
|
| 16 |
Doxepin hydrochloride
(4 times)
|
Chemistry Techniques, Analytical
(1 time)
|
ASM (2 times)
Cer (2 times)
TCAs (2 times)
|
2017 Doxepin Mitigates Noise-induced Neuronal Damage in Primary Auditory Cortex of Mice via Suppression of Acid Sphingomyelinase/Ceramide Pathway.
|
| 17 |
1,4-dioxane
(3 times)
|
Chemistry
(2 times)
|
BSLA (1 time)
cryo-TEM (1 time)
DLS (1 time)
|
2007 Effect of organic solvents on J aggregation of pseudoisocyanine dye at mica/water interfaces: morphological transition from three-dimension to two-dimension.
|
| 18 |
doxycycline gel
(3 times)
|
Dentistry
(2 times)
|
SRP (2 times)
Aa (1 time)
CAL (1 time)
|
2005 Non-surgical periodontal therapy with adjunctive topical doxycycline: a double-masked, randomized, controlled multicenter study. II. Microbiological results.
|
| 19 |
pectin-doxorubicin
(3 times)
|
Pharmacology
(2 times)
|
BC2Tama (1 time)
DOXPCB (1 time)
GI (1 time)
|
2018 Effect of lutein and doxorubicin combinatorial therapy on S180 cell proliferation and tumor growth.
|
| 20 |
(5,5-(2)H(2))-deoxy-d-xylose
(2 times)
|
Chemistry
(2 times)
|
enantio-MDGC-MS (1 time)
SBSE (1 time)
|
2002 Differential incorporation of 1-deoxy-D-xylulose into (3S)-linalool and geraniol in grape berry exocarp and mesocarp.
|
| 21 |
acute-doxorubicin
(2 times)
|
Cardiology
(1 time)
|
EPC (1 time)
HCC (1 time)
TPO (1 time)
|
2011 Thrombopoietin protects against doxorubicin-induced cardiomyopathy, improves cardiac function, and reversely alters specific signalling networks.
|
| 22 |
agents-doxorubicin
(2 times)
|
Medicine
(1 time)
|
CPT (1 time)
gamma-GCS (1 time)
HA (1 time)
|
2013 Purine nucleoside analog--sulfinosine modulates diverse mechanisms of cancer progression in multi-drug resistant cancer cell lines.
|
| 23 |
anthracyclines-doxorubicin
(2 times)
|
Pharmacology
(1 time)
|
CTAB (1 time)
DAU (1 time)
DOSY (1 time)
|
2015 Low-density lipoprotein peptide-combined DNA nanocomplex as an efficient anticancer drug delivery vehicle.
|
| 24 |
DOX loaded chitosan/carboxymethyl chitosan nanogels
(2 times)
|
Biochemistry
(1 time)
|
GI (1 time)
MMS (1 time)
P-gp (1 time)
|
2016 Multilayer micro-dispersing system as oral carriers for co-delivery of doxorubicin hydrochloride and P-gp inhibitor.
|
| 25 |
doxanthrine
(2 times)
|
Psychopharmacology
(2 times)
|
AUC (1 time)
DHX (1 time)
PD (1 time)
|
2008 Comparison of the enantiomers of (+/-)-doxanthrine, a high efficacy full dopamine D(1) receptor agonist, and a reversal of enantioselectivity at D(1) versus alpha(2C) adrenergic receptors.
|
| 26 |
doxantrazole
(2 times)
|
Gastroenterology
(2 times)
|
FAE (2 times)
CRHR (1 time)
HRP (1 time)
|
2010 Stress-induced barrier disruption of rat follicle-associated epithelium involves corticotropin-releasing hormone, acetylcholine, substance P, and mast cells.
|
| 27 |
doxorubicin base
(2 times)
|
Nanotechnology
(1 time)
|
CMC (1 time)
CSO (1 time)
CSO-LA (1 time)
|
2010 Linoleic acid-grafted chitosan oligosaccharide micelles for intracellular drug delivery and reverse drug resistance of tumor cells.
|
| 28 |
doxorubicin group
(2 times)
|
Pharmacology
(1 time)
|
BHB (1 time)
Sham (1 time)
|
2021 Cardioprotective Roles of beta-Hydroxybutyrate Against Doxorubicin Induced Cardiotoxicity.
|
| 29 |
doxorubicin-based chemotherapy
(2 times)
|
General Surgery
(1 time)
|
CD (1 time)
CHF (1 time)
DLBCL (1 time)
|
2004 The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma.
|
| 30 |
doxorubicin-induced
(2 times)
|
Medicine
(1 time)
|
DOX group (1 time)
HE (1 time)
HO-1 (1 time)
|
2011 Prostacyclin administration as a beneficial supplement to the conventional cancer chemotherapy.
|
| 31 |
(DSPE)-doxorubicin
(1 time)
|
Biomedical Engineering
(1 time)
|
DSPE (1 time)
DSPE-mPEG2000 (1 time)
Tet (1 time)
|
2017 Hybrid Prodrug Nanoparticles with Tumor Penetration and Programmed Drug Activation for Enhanced Chemoresistant Cancer Therapy.
|
| 32 |
(Tf-M-DOX/PSO), coencapsulating doxorubicin
(1 time)
|
Geriatrics
(1 time)
|
MDR (1 time)
PSO (1 time)
|
2020 Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen.
|
| 33 |
(vc)-doxorubicin
(1 time)
|
Nanotechnology
(1 time)
|
ADCs (1 time)
BSA (1 time)
EGFR (1 time)
|
2021 EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy.
|
| 34 |
1,3-dioxolan-4-one
(1 time)
|
Chemistry
(1 time)
|
---
|
2022 Sustainability and Polyesters: Beyond Metals and Monomers to Function and Fate.
|
| 35 |
1-(4-X-2,5-dimethoxyphenyl)-2-aminopropane
(1 time)
|
Chemistry
(1 time)
|
XBs (1 time)
|
2021 5-HT2 Receptor Subfamily and the Halogen Bond Promise.
|
| 36 |
2,5-dimethoxyamphetamines
(1 time)
|
Chemistry Techniques, Analytical
(1 time)
|
CID (1 time)
NLFs (1 time)
NPS (1 time)
|
2017 Characterization of hallucinogenic phenethylamines using high-resolution mass spectrometry for non-targeted screening purposes.
|
| 37 |
alpha'-dimercapto-o-xylene
(1 time)
|
Toxicology
(1 time)
|
BDT (1 time)
DDOX (1 time)
DMPA (1 time)
|
1990 Structural influences on intracellular cadmium mobilization by dithiols.
|
| 38 |
An-PEG-DOX-AuNPs, was loaded with doxorubicin
(1 time)
|
Biomedical Engineering
(1 time)
|
LRP1 (1 time)
|
2014 Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.
|
| 39 |
analogs--doxorubicin
(1 time)
|
Biology
(1 time)
|
ACR (1 time)
|
1998 Structurally different anthracyclines provoke different effects on cell cycle and tumor B cell differentiation.
|
| 40 |
BR96-doxorubicin
(1 time)
|
Antineoplastic Agents
(1 time)
|
---
|
1997 Disposition of conjugate-bound and free doxorubicin in tumor-bearing mice following administration of a BR96-doxorubicin immunoconjugate (BMS 182248).
|
| 41 |
cisplatin-doxorubicin
(1 time)
|
Carbohydrates
(1 time)
|
---
|
2016 Cisplatin-crosslinked glutathione-sensitive micelles loaded with doxorubicin for combination and targeted therapy of tumors.
|
| 42 |
cycler-doxorubicin
(1 time)
|
Chemistry
(1 time)
|
FA (1 time)
TPP (1 time)
|
2012 Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes.
|
| 43 |
deoxy-D-xylulose
(1 time)
|
Medicine
(1 time)
|
---
|
1999 Induced biosynthesis of insect semiochemicals in plants.
|
| 44 |
deoxycholate
(1 time)
|
Cell Biology
(1 time)
|
---
|
1975 [Some properties of preparations of Na+ and k+-ATPase treated with deoxycholate].
|
| 45 |
deoxyglucose
(1 time)
|
Obstetrics
(1 time)
|
AIB (1 time)
Cd (1 time)
VitB12 (1 time)
|
1984 Effects of cadmium on the placental uptake and transport to the fetus of nutrients.
|
| 46 |
DePQu-DOX NPs coloading doxorubicin
(1 time)
|
Biocompatible Materials
(1 time)
|
ATP (1 time)
QU (1 time)
|
2020 Tissue-Specific Regulation of Reactive Oxygen Species by an ATP-Responsive Nanoregulator Enhances Anticancer Efficacy and Reduces Anthracycline-Induced Cardiotoxicity.
|
| 47 |
desferrioxamine
(1 time)
|
Biochemistry
(1 time)
|
5 alpha-OOH (1 time)
BHT (1 time)
|
1988 Ascorbate-enhanced lipid peroxidation in photooxidized cell membranes: cholesterol product analysis as a probe of reaction mechanism.
|
| 48 |
develop functional Eu/MBGs by combining excellent apatite-mineralization ability, controllable drug
(1 time)
|
|
---
|
2018 Design and Evaluation of Europium Containing Mesoporous Bioactive Glass Nanospheres: Doxorubicin Release Kinetics and Inhibitory Effect on Osteosarcoma MG 63 Cells.
|
| 49 |
developed a heterogeneous oxidant, i.e., a solid redox polymer
(1 time)
|
Biology
(1 time)
|
BV (1 time)
NOMs (1 time)
|
2017 Highly efficient and environmentally benign As(III) pre-oxidation in water by using a solid redox polymer.
|
| 50 |
Dewar- o-xylylene
(1 time)
|
Chemistry
(1 time)
|
PDOX (1 time)
POX (1 time)
|
2018 Polymer Valence Isomerism: Poly(Dewar- o-xylylene)s.
|
| 51 |
dexamethasone-oxetanone
(1 time)
|
Biochemistry
(1 time)
|
HTC (1 time)
TAT (1 time)
|
1986 Analysis of the relation between receptor binding affinity and antagonist efficacy of antiglucocorticoids.
|
| 52 |
dextran-doxorubicin
(1 time)
|
Pharmacological Phenomena
(1 time)
|
ATRP (1 time)
TME (1 time)
|
2020 The design and synthesis of dextran-doxorubicin prodrug-based pH-sensitive drug delivery system for improving chemotherapy efficacy.
|
| 53 |
dicloxacillin
(1 time)
|
Biochemistry
(1 time)
|
AMP (1 time)
CL (1 time)
OX (1 time)
|
2016 Radical-scavenging activity of penicillin G, ampicillin, oxacillin, and dicloxacillin.
|
| 54 |
different concentration of the B. persica extract
(1 time)
|
Molecular Biology
(1 time)
|
GC-MS (1 time)
MTT (1 time)
|
2019 The Blepharis persica seed hydroalcoholic extract synergistically enhances the apoptotic effect of doxorubicin in human colon cancer and gastric cancer cells.
|
| 55 |
dioxyxylene
(1 time)
|
Biochemistry
(1 time)
|
---
|
2000 Polymer-supported and chemoenzymatic synthesis of the Neisseria meningitidis pentasaccharide: a methodological comparison.
|
| 56 |
diphenol oxidase
(1 time)
|
Molecular Biology
(1 time)
|
POX (1 time)
|
1991 Drosophila melanogaster diphenol oxidase A2: gene structure and homology with the mouse mast-cell tum- transplantation antigen, P91A.
|
| 57 |
dissolved oxygen multi-electrode sensor
(1 time)
|
Biotechnology
(1 time)
|
PCA (1 time)
|
2006 Detection and identification of bacteria using antibiotic susceptibility and a multi-array electrochemical sensor with pattern recognition.
|
| 58 |
DMSP-amine oxidase
(1 time)
|
Physiology
(1 time)
|
DMSP (1 time)
DMSP-amine (1 time)
SDC (1 time)
|
2000 Biochemical evidence for two novel enzymes in the biosynthesis of 3-dimethylsulfoniopropionate in Spartina alterniflora.
|
| 59 |
DNA origami/doxorubicin
(1 time)
|
Biocompatible Materials
(1 time)
|
---
|
2018 Time-lapse live cell imaging to monitor doxorubicin release from DNA origami nanostructures.
|
| 60 |
docking, ONIOM, and XO
(1 time)
|
Chemistry
(1 time)
|
---
|
2017 Structure-Based Rational Design of Novel Inhibitors Against Fructose-1,6-Bisphosphate Aldolase from Candida albicans.
|
| 61 |
DOX by confocal microscopy and fluorescence spectrophotometry showed that M-MSN
(1 time)
|
Biomedical Engineering
(1 time)
|
FA (1 time)
|
2016 Folate-Functionalized Magnetic-Mesoporous Silica Nanoparticles for Drug/Gene Codelivery To Potentiate the Antitumor Efficacy.
|
| 62 |
DOX combined with olaratumab (OLA)
(1 time)
|
Biochemistry
(1 time)
|
PAL (2 times)
PAZ (2 times)
DOC (1 time)
|
2019 Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) model.
|
| 63 |
DOX concentration
(1 time)
|
Chemistry Techniques, Analytical
(1 time)
|
ECS (1 time)
|
2016 A general strategy to facilely design ratiometric electrochemical sensors in electrolyte solution by directly using a bare electrode for dual-signal sensing of analytes.
|
| 64 |
DOX group
(1 time)
|
|
IL-1beta (1 time)
LC3B (1 time)
MDA (1 time)
|
2023 Modulatory Role of Autophagy in Metformin Therapeutic Activity toward Doxorubicin-Induced Nephrotoxicity.
|
| 65 |
DOX model group
(1 time)
|
Biomedical Engineering
(1 time)
|
H2S (1 time)
SD (1 time)
|
2021 H2S improves doxorubicin-induced myocardial fibrosis by inhibiting oxidative stress and apoptosis via Keap1-Nrf2.
|
| 66 |
DOX prodrug
(1 time)
|
Biocompatible Materials
(1 time)
|
MDR (1 time)
PTX (1 time)
|
2021 Novel multi-stimuli responsive functionalized PEG-based co-delivery nanovehicles toward sustainable treatments of multidrug resistant tumor.
|
| 67 |
DOX release and tumor accumulation of mLTSL
(1 time)
|
Pharmacology
(1 time)
|
IONPs (1 time)
LTSL (1 time)
MRI (1 time)
|
2021 PD1 blockade potentiates the therapeutic efficacy of photothermally-activated and MRI-guided low temperature-sensitive magnetoliposomes.
|
| 68 |
DOX release from pRGO@MS
(1 time)
|
Biomedical Engineering
(1 time)
|
DA (1 time)
GO (1 time)
HA (1 time)
|
2016 Mesoporous Silica Coated Polydopamine Functionalized Reduced Graphene Oxide for Synergistic Targeted Chemo-Photothermal Therapy.
|
| 69 |
DOX release from YSPMOs
(1 time)
|
Nanotechnology
(1 time)
|
CuS (1 time)
PTT (1 time)
YSPMOs (1 time)
|
2018 Fabrication of multifunctional triple-responsive platform based on CuS-capped periodic mesoporous organosilica nanoparticles for chemo-photothermal therapy.
|
| 70 |
DOX treated
(1 time)
|
Antineoplastic Agents
(1 time)
|
US (1 time)
|
2007 Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells.
|
| 71 |
DOX was released from HA-HMCN
(1 time)
|
Nanotechnology
(1 time)
|
GQD (1 time)
HA (1 time)
HMCN (1 time)
|
2018 Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy.
|
| 72 |
DOX, SIM, or a combination of them
(1 time)
|
|
DMPS (1 time)
POPC (1 time)
SIM (1 time)
|
2022 Simvastatin Coadministration Modulates the Electrostatically Driven Incorporation of Doxorubicin into Model Lipid and Cell Membranes.
|
| 73 |
DOX-DCMs
(1 time)
|
Nanotechnology
(1 time)
|
AUC (1 time)
NAC (1 time)
|
2018 Reversibly disulfide cross-linked micelles improve the pharmacokinetics and facilitate the targeted, on-demand delivery of doxorubicin in the treatment of B-cell lymphoma.
|
| 74 |
DOX-HAP
(1 time)
|
Neoplasms
(1 time)
|
DOX-HAP (1 time)
HAP (1 time)
|
1993 Implantation treatment method of slow release anticancer doxorubicin containing hydroxyapatite (DOX-HAP) complex. A basic study of a new treatment for hepatic cancer.
|
| 75 |
DOX-loaded CS/CMCS nanoparticles
(1 time)
|
Chemistry
(1 time)
|
CMCS (1 time)
CS (1 time)
|
2013 Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
|
| 76 |
DOX-loaded PGMNs
(1 time)
|
Pharmacology
(1 time)
|
PGMNs (2 times)
|
2010 PEG-modified GoldMag nanoparticles (PGMNs) combined with the magnetic field for local drug delivery.
|
| 77 |
DOX-MSN-S-S-PNIPAM compared to the free drug
(1 time)
|
Technology, Pharmaceutical
(1 time)
|
ATRP (1 time)
BET (1 time)
DLS (1 time)
|
2023 Enzyme and Thermo Dual-stimuli Responsive DOX Carrier Based on PNIPAM Conjugated Mesoporous Silica.
|
| 78 |
DOX-treated mice
(1 time)
|
Cachexia
(1 time)
|
sACVR2B-Fc (1 time)
|
2017 Prevention of chemotherapy-induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle.
|
| 79 |
DOX-treated sedentary
(1 time)
|
|
CON (1 time)
ET (1 time)
FS (1 time)
|
2021 Endurance Exercise Training Prevents Elevation of Soluble ST2 in Mice with Doxorubicin-Induced Myocardial Injury.
|
| 80 |
DOX/NP
(1 time)
|
|
DLE (1 time)
EE (1 time)
PDI (1 time)
|
2020 Characterization and targeting ability evaluation of cell-penetrating peptide LyP-1 modified alginate-based nanoparticles.
|
| 81 |
Doxacurium
(1 time)
|
Anesthesiology
(1 time)
|
CABG (1 time)
HR (1 time)
MAP (1 time)
|
1994 Hemodynamic and pharmacodynamic comparison of doxacurium and high-dose vecuronium during coronary artery bypass surgery: a cost-benefit study.
|
| 82 |
doxercalciferol
(1 time)
|
Endocrinology
(1 time)
|
---
|
2018 Doxercalciferol Alleviates Bone Deteriorations and Cartilage Degeneration in Aging Mice.
|
| 83 |
DOXHCl
(1 time)
|
Biocompatible Materials
(1 time)
|
EPR (1 time)
HA-NCs (1 time)
|
2016 Dual cellular stimuli-responsive hydrogel nanocapsules for delivery of anticancer drugs.
|
| 84 |
doxofylline
(1 time)
|
Pharmacology
(1 time)
|
DFO (1 time)
HSC (1 time)
|
2023 Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway.
|
| 85 |
doxorubicin (DOX)
(1 time)
|
Biochemistry
(1 time)
|
PAL (2 times)
PAZ (2 times)
DOC (1 time)
|
2019 Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) model.
|
| 86 |
Doxorubicin activity
(1 time)
|
Medicine
(1 time)
|
---
|
2007 [Pharmacological mechanisms of Doxorubicin activity (DOX) - current state of knowledge].
|
| 87 |
doxorubicin anticancer drug
(1 time)
|
Biochemistry
(1 time)
|
HeLa (1 time)
MNP (1 time)
MRI (1 time)
|
2022 Fabrication of a magnetic nanocarrier for doxorubicin delivery based on hyperbranched polyglycerol and carboxymethyl cellulose: An investigation on the effect of borax cross-linker on pH-sensitivity.
|
| 88 |
doxorubicin anticancer molecule
(1 time)
|
|
SCC-DFTB (1 time)
|
2020 TETT-functionalized TiO2 nanoparticles for DOX loading: a quantum mechanical study at the atomic scale.
|
| 89 |
doxorubicin HCl liposomal injection
(1 time)
|
Pharmacology
(1 time)
|
HCC (1 time)
MB (1 time)
UTMD (1 time)
|
2015 Effectiveness of localized ultrasound-targeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model.
|
| 90 |
doxorubicin hydrochloride drug molecules
(1 time)
|
Natural Science Disciplines
(1 time)
|
FTIR (1 time)
PL (1 time)
SDNA (1 time)
|
2015 Chemical and Physical Characteristics of Doxorubicin Hydrochloride Drug-Doped Salmon DNA Thin Films.
|
| 91 |
doxorubicin hydrochloride:paclitaxel
(1 time)
|
Nanotechnology
(1 time)
|
ACMF (1 time)
MMNPs (1 time)
|
2015 Enhanced cell apoptosis triggered by a multi modal mesoporous amphiphilic drug delivery system.
|
| 92 |
doxorubicin in the free base form
(1 time)
|
Biomedical Engineering
(1 time)
|
DLS (1 time)
GPC (1 time)
mPEG (1 time)
|
2009 Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
|
| 93 |
doxorubicin or adriamycin
(1 time)
|
Biophysics
(1 time)
|
SERS (1 time)
THP-ADM (1 time)
|
1991 Selective analysis of antitumor drug interaction with living cancer cells as probed by surface-enhanced Raman spectroscopy.
|
| 94 |
doxorubicin treatment
(1 time)
|
Biochemistry
(1 time)
|
ATP (1 time)
CTR (1 time)
LDH (1 time)
|
2022 Protective effect of low-dose radiation on doxorubicin-induced brain injury in mice.
|
| 95 |
doxorubicin treatment group
(1 time)
|
Biomedical Research
(1 time)
|
CON (1 time)
DEX (1 time)
PTEN (1 time)
|
2020 Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p.
|
| 96 |
Doxorubicin was administered alone
(1 time)
|
Cell Biology
(1 time)
|
---
|
2012 The redox imbalance and the reduction of contractile protein content in rat hearts administered with L-thyroxine and Doxorubicin.
|
| 97 |
doxorubicin without dexrazoxane
(1 time)
|
Neoplasms
(1 time)
|
AR (1 time)
DOX/DZX (1 time)
SAECG (1 time)
|
2001 Signal-averaged electrocardiography in survivors of Hodgkin's disease treated with and without dexrazoxane.
|
| 98 |
doxorubicin, a chemotherapeutic agent
(1 time)
|
|
CDT (1 time)
CT (1 time)
MRI (1 time)
|
2019 Upconversion-mediated ZnFe2O4 nanoplatform for NIR-enhanced chemodynamic and photodynamic therapy.
|
| 99 |
doxorubicin, either in its traditional
(1 time)
|
Neoplasms
(1 time)
|
ACH (1 time)
AUC (1 time)
CHF (1 time)
|
2007 The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines.
|
| 100 |
Doxorubicin, PEG-LP
(1 time)
|
Chemistry
(1 time)
|
ECM (1 time)
EPR (1 time)
PEG-LP (1 time)
|
2016 Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors.
|
A Search Service for Abbreviation / Long Form